19 May 2013
Keywords: Otsuka, EMEA, Abilify, Antidepresant, Schizophrenia
Article | 20 November 2009
The European Medicines Agency(EMEA) has been formally notified by Otsuka Pharmaceutical Europe, a unit of the Japanese drugmaker, of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 November 2009
19 November 2009
17 May 2013
© 2013 thepharmaletter.com